Cronos Group (CRON) Competitors $1.95 +0.08 (+4.28%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CRON vs. MRUS, TWST, ACAD, VCEL, MOR, SWTX, KYMR, ZLAB, GMTX, and VERAShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Merus (MRUS), Twist Bioscience (TWST), ACADIA Pharmaceuticals (ACAD), Vericel (VCEL), MorphoSys (MOR), SpringWorks Therapeutics (SWTX), Kymera Therapeutics (KYMR), Zai Lab (ZLAB), Gemini Therapeutics (GMTX), and Vera Therapeutics (VERA). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Merus Twist Bioscience ACADIA Pharmaceuticals Vericel MorphoSys SpringWorks Therapeutics Kymera Therapeutics Zai Lab Gemini Therapeutics Vera Therapeutics Cronos Group (NASDAQ:CRON) and Merus (NASDAQ:MRUS) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation, risk and community ranking. Is CRON or MRUS more profitable? Cronos Group has a net margin of -42.65% compared to Merus' net margin of -680.61%. Cronos Group's return on equity of -2.56% beat Merus' return on equity.Company Net Margins Return on Equity Return on Assets Cronos Group-42.65% -2.56% -2.47% Merus -680.61%-38.89%-31.16% Which has stronger valuation and earnings, CRON or MRUS? Cronos Group has higher revenue and earnings than Merus. Cronos Group is trading at a lower price-to-earnings ratio than Merus, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCronos Group$111.23M6.70-$73.96M-$0.13-15.00Merus$43.95M65.19-$154.94M-$3.95-10.59 Do institutionals & insiders hold more shares of CRON or MRUS? 8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 96.1% of Merus shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by insiders. Comparatively, 4.6% of Merus shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk and volatility, CRON or MRUS? Cronos Group has a beta of 0.99, indicating that its share price is 1% less volatile than the S&P 500. Comparatively, Merus has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Does the media prefer CRON or MRUS? In the previous week, Merus had 7 more articles in the media than Cronos Group. MarketBeat recorded 9 mentions for Merus and 2 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.50 beat Merus' score of 0.37 indicating that Cronos Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cronos Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Merus 3 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Do analysts prefer CRON or MRUS? Cronos Group currently has a consensus target price of $3.00, suggesting a potential upside of 53.85%. Merus has a consensus target price of $85.64, suggesting a potential upside of 104.63%. Given Merus' stronger consensus rating and higher probable upside, analysts plainly believe Merus is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cronos Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Merus 0 Sell rating(s) 0 Hold rating(s) 12 Buy rating(s) 2 Strong Buy rating(s) 3.14 Does the MarketBeat Community believe in CRON or MRUS? Cronos Group received 111 more outperform votes than Merus when rated by MarketBeat users. However, 67.11% of users gave Merus an outperform vote while only 61.13% of users gave Cronos Group an outperform vote. CompanyUnderperformOutperformCronos GroupOutperform Votes46461.13% Underperform Votes29538.87% MerusOutperform Votes35367.11% Underperform Votes17332.89% SummaryMerus beats Cronos Group on 10 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$714.89M$378.11M$5.14B$9.08BDividend YieldN/AN/A5.09%4.23%P/E Ratio-15.0032.5989.8217.18Price / Sales6.706.081,116.21116.95Price / CashN/A10.6642.8937.86Price / Book0.681.884.784.78Net Income-$73.96M-$50.37M$120.23M$225.60M7 Day Performance1.04%-3.56%-1.92%-1.23%1 Month Performance-4.88%-7.00%11.49%3.36%1 Year Performance2.09%-6.41%30.57%16.60% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos Group1.8534 of 5 stars$1.95+4.3%$3.00+53.8%+4.8%$714.89M$111.23M-15.00356News CoverageMRUSMerus2.7827 of 5 stars$42.78-0.1%$85.64+100.2%+61.7%$2.93B$43.95M-10.8437TWSTTwist Bioscience2.5561 of 5 stars$48.86+2.9%$51.90+6.2%+36.7%$2.90B$312.97M-13.19990ACADACADIA Pharmaceuticals3.8468 of 5 stars$17.35+0.5%$25.60+47.6%-41.9%$2.89B$726.44M22.13510VCELVericel1.4381 of 5 stars$57.97+0.9%$59.71+3.0%+66.0%$2.86B$226.84M957.83300Analyst ForecastMORMorphoSys0.127 of 5 stars$18.96+2.4%$14.33-24.4%N/A$2.86B$238.28M-5.45730News CoverageSWTXSpringWorks Therapeutics2.0114 of 5 stars$38.16-0.4%$69.50+82.1%+11.3%$2.84B$5.45M-9.87305KYMRKymera Therapeutics2.27 of 5 stars$43.73+3.8%$53.88+23.2%+66.0%$2.83B$87.56M-18.00170ZLABZai Lab1.7093 of 5 stars$26.06-1.0%$55.00+111.1%-7.4%$2.83B$355.75M-9.512,175GMTXGemini TherapeuticsN/A$64.89+1.0%N/A+10.4%$2.81BN/A-64.8930VERAVera Therapeutics3.481 of 5 stars$44.38+0.7%$59.22+33.4%+180.4%$2.81BN/A-16.8840Insider Trade Related Companies and Tools Related Companies MRUS Alternatives TWST Alternatives ACAD Alternatives VCEL Alternatives MOR Alternatives SWTX Alternatives KYMR Alternatives ZLAB Alternatives GMTX Alternatives VERA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CRON) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CRON Stock Alerts